Jendrny Cathleen, Beck-Sickinger Annette G
Institute of Biochemistry, Faculty of Biosciences, Pharmacy and Psychology, Universität Leipzig, Brüderstrasse 34, 04103, Leipzig, Germany.
Chembiochem. 2016 Apr 15;17(8):719-26. doi: 10.1002/cbic.201500539. Epub 2015 Dec 22.
Serpin proteins irreversibly inhibit serine proteases, but only a small part of the serpin reactive-center loop (RCL) is responsible for the initial protein-protein interaction (PPI). To develop peptidic protease inhibitors, kallikrein-related peptidases 7 (KLK7) and 5 (KLK5) were chosen. Firstly, we demonstrated that short peptides derived from RCL sequences can be cleaved by KLK7 in a substrate-like manner. Next, these substrates were grafted onto the protease-binding loop of sunflower trypsin inhibitor-1 (SFTI-1). Peptides based on kallistatin, α1 -antichymotrypsin, and protein C inhibitor (PCI) inhibited KLK7 with Ki =0.4, 0.5, and 0.7 μm, respectively. In contrast, the trypsin-like KLK5 was only blocked by the peptide derived from PCI (Ki =0.6 μm). Thus, serpin function can be mimicked by introducing its PPI site into the rigid structure of the SFTI-1 scaffold. This approach might be applicable not only to KLKs but also to other serine protease members, thus opening up new therapeutic fields.
丝氨酸蛋白酶抑制剂(Serpin)蛋白可不可逆地抑制丝氨酸蛋白酶,但只有一小部分丝氨酸蛋白酶抑制剂反应中心环(RCL)负责最初的蛋白质-蛋白质相互作用(PPI)。为了开发肽类蛋白酶抑制剂,我们选择了激肽释放酶相关肽酶7(KLK7)和5(KLK5)。首先,我们证明了源自RCL序列的短肽可以被KLK7以类似底物的方式切割。接下来,将这些底物嫁接到向日葵胰蛋白酶抑制剂-1(SFTI-1)的蛋白酶结合环上。基于激肽释放酶抑制蛋白、α1-抗糜蛋白酶和蛋白C抑制剂(PCI)的肽分别以Ki = 0.4、0.5和0.7μm的浓度抑制KLK7。相比之下,类胰蛋白酶KLK5仅被源自PCI的肽阻断(Ki = 0.6μm)。因此,可以通过将丝氨酸蛋白酶抑制剂的PPI位点引入SFTI-1支架的刚性结构来模拟其功能。这种方法不仅可能适用于激肽释放酶相关肽酶,也可能适用于其他丝氨酸蛋白酶成员,从而开辟新的治疗领域。